Cardiac Relapse of Acute Lymphoblastic Leukemia Following Hematopoietic Stem Cell Transplantation: A Case Report and Review of Literature

Isolated extramedullary relapse of acute lymphoblastic leukemia (ALL) occurs in soft tissues and various organs outside the testis and central nervous system. Treatments such as hematopoietic stem cell transplantation and more novel modalities such as immunotherapy have eradicated ALL at extramedull...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Irtiza N. Sheikh, Dristhi Ragoonanan, Anna Franklin, Chandra Srinivasan, Bhiong Zhao, Demetrios Petropoulos, Kris M. Mahadeo, Priti Tewari, Sajad J. Khazal
Formato: article
Lenguaje:EN
Publicado: MDPI AG 2021
Materias:
Acceso en línea:https://doaj.org/article/b7dbced2fdb54e5e9a0ad591de76e377
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:b7dbced2fdb54e5e9a0ad591de76e377
record_format dspace
spelling oai:doaj.org-article:b7dbced2fdb54e5e9a0ad591de76e3772021-11-25T17:04:22ZCardiac Relapse of Acute Lymphoblastic Leukemia Following Hematopoietic Stem Cell Transplantation: A Case Report and Review of Literature10.3390/cancers132258142072-6694https://doaj.org/article/b7dbced2fdb54e5e9a0ad591de76e3772021-11-01T00:00:00Zhttps://www.mdpi.com/2072-6694/13/22/5814https://doaj.org/toc/2072-6694Isolated extramedullary relapse of acute lymphoblastic leukemia (ALL) occurs in soft tissues and various organs outside the testis and central nervous system. Treatments such as hematopoietic stem cell transplantation and more novel modalities such as immunotherapy have eradicated ALL at extramedullary sites. In some instances, survival times for relapsed ALL at these sites are longer than those for relapsed disease involving only the bone marrow. Isolated relapse of ALL in the myocardium is rare, especially in children, making diagnosis and treatment of it difficult. More recent treatment options such as chimeric antigen receptor T-cell therapy carry a high risk of cytokine release syndrome and associated risk of worsening cardiac function. Herein we present the case of an 11-year-old boy who presented with relapsed symptomatic B-cell ALL in the myocardium following allogeneic hematopoietic stem cell transplantation. This is an unusual presentation of relapsed ALL and this case demonstrates the associated challenges in its diagnosis and treatment. The case report is followed by a literature review of the advances in treatment of pediatric leukemia and their application to extramedullary relapse of this disease in particular.Irtiza N. SheikhDristhi RagoonananAnna FranklinChandra SrinivasanBhiong ZhaoDemetrios PetropoulosKris M. MahadeoPriti TewariSajad J. KhazalMDPI AGarticlerelapse/refractory leukemiaextramedullary diseasestem cell transplantationCAR T-cell therapycardiac relapsepediatricsNeoplasms. Tumors. Oncology. Including cancer and carcinogensRC254-282ENCancers, Vol 13, Iss 5814, p 5814 (2021)
institution DOAJ
collection DOAJ
language EN
topic relapse/refractory leukemia
extramedullary disease
stem cell transplantation
CAR T-cell therapy
cardiac relapse
pediatrics
Neoplasms. Tumors. Oncology. Including cancer and carcinogens
RC254-282
spellingShingle relapse/refractory leukemia
extramedullary disease
stem cell transplantation
CAR T-cell therapy
cardiac relapse
pediatrics
Neoplasms. Tumors. Oncology. Including cancer and carcinogens
RC254-282
Irtiza N. Sheikh
Dristhi Ragoonanan
Anna Franklin
Chandra Srinivasan
Bhiong Zhao
Demetrios Petropoulos
Kris M. Mahadeo
Priti Tewari
Sajad J. Khazal
Cardiac Relapse of Acute Lymphoblastic Leukemia Following Hematopoietic Stem Cell Transplantation: A Case Report and Review of Literature
description Isolated extramedullary relapse of acute lymphoblastic leukemia (ALL) occurs in soft tissues and various organs outside the testis and central nervous system. Treatments such as hematopoietic stem cell transplantation and more novel modalities such as immunotherapy have eradicated ALL at extramedullary sites. In some instances, survival times for relapsed ALL at these sites are longer than those for relapsed disease involving only the bone marrow. Isolated relapse of ALL in the myocardium is rare, especially in children, making diagnosis and treatment of it difficult. More recent treatment options such as chimeric antigen receptor T-cell therapy carry a high risk of cytokine release syndrome and associated risk of worsening cardiac function. Herein we present the case of an 11-year-old boy who presented with relapsed symptomatic B-cell ALL in the myocardium following allogeneic hematopoietic stem cell transplantation. This is an unusual presentation of relapsed ALL and this case demonstrates the associated challenges in its diagnosis and treatment. The case report is followed by a literature review of the advances in treatment of pediatric leukemia and their application to extramedullary relapse of this disease in particular.
format article
author Irtiza N. Sheikh
Dristhi Ragoonanan
Anna Franklin
Chandra Srinivasan
Bhiong Zhao
Demetrios Petropoulos
Kris M. Mahadeo
Priti Tewari
Sajad J. Khazal
author_facet Irtiza N. Sheikh
Dristhi Ragoonanan
Anna Franklin
Chandra Srinivasan
Bhiong Zhao
Demetrios Petropoulos
Kris M. Mahadeo
Priti Tewari
Sajad J. Khazal
author_sort Irtiza N. Sheikh
title Cardiac Relapse of Acute Lymphoblastic Leukemia Following Hematopoietic Stem Cell Transplantation: A Case Report and Review of Literature
title_short Cardiac Relapse of Acute Lymphoblastic Leukemia Following Hematopoietic Stem Cell Transplantation: A Case Report and Review of Literature
title_full Cardiac Relapse of Acute Lymphoblastic Leukemia Following Hematopoietic Stem Cell Transplantation: A Case Report and Review of Literature
title_fullStr Cardiac Relapse of Acute Lymphoblastic Leukemia Following Hematopoietic Stem Cell Transplantation: A Case Report and Review of Literature
title_full_unstemmed Cardiac Relapse of Acute Lymphoblastic Leukemia Following Hematopoietic Stem Cell Transplantation: A Case Report and Review of Literature
title_sort cardiac relapse of acute lymphoblastic leukemia following hematopoietic stem cell transplantation: a case report and review of literature
publisher MDPI AG
publishDate 2021
url https://doaj.org/article/b7dbced2fdb54e5e9a0ad591de76e377
work_keys_str_mv AT irtizansheikh cardiacrelapseofacutelymphoblasticleukemiafollowinghematopoieticstemcelltransplantationacasereportandreviewofliterature
AT dristhiragoonanan cardiacrelapseofacutelymphoblasticleukemiafollowinghematopoieticstemcelltransplantationacasereportandreviewofliterature
AT annafranklin cardiacrelapseofacutelymphoblasticleukemiafollowinghematopoieticstemcelltransplantationacasereportandreviewofliterature
AT chandrasrinivasan cardiacrelapseofacutelymphoblasticleukemiafollowinghematopoieticstemcelltransplantationacasereportandreviewofliterature
AT bhiongzhao cardiacrelapseofacutelymphoblasticleukemiafollowinghematopoieticstemcelltransplantationacasereportandreviewofliterature
AT demetriospetropoulos cardiacrelapseofacutelymphoblasticleukemiafollowinghematopoieticstemcelltransplantationacasereportandreviewofliterature
AT krismmahadeo cardiacrelapseofacutelymphoblasticleukemiafollowinghematopoieticstemcelltransplantationacasereportandreviewofliterature
AT prititewari cardiacrelapseofacutelymphoblasticleukemiafollowinghematopoieticstemcelltransplantationacasereportandreviewofliterature
AT sajadjkhazal cardiacrelapseofacutelymphoblasticleukemiafollowinghematopoieticstemcelltransplantationacasereportandreviewofliterature
_version_ 1718412736245792768